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Resting-state functional connectivity is a promising biomarker for Alzheimer’s disease.
However, previous resting-state functional magnetic resonance imaging studies in
Alzheimer’s disease and amnestic mild cognitive impairment (aMCI) have shown limited
reproducibility as they have had small sample sizes and substantial variation in
study protocol. We sought to identify functional brain networks and connections that
could consistently discriminate normal aging from aMCI despite variations in scanner
manufacturer, imaging protocol, and diagnostic procedure. We therefore combined four
datasets collected independently, including 112 healthy controls and 143 patients with
aMCI. We systematically tested multiple brain connections for associations with aMCI
using a weighted average routinely used in meta-analyses. The largest effects involved
the superior medial frontal cortex (including the anterior cingulate), dorsomedial prefrontal
cortex, striatum, and middle temporal lobe. Compared with controls, patients with aMCI
exhibited significantly decreased connectivity between default mode network nodes
and between regions of the cortico-striatal-thalamic loop. Despite the heterogeneity
of methods among the four datasets, we identified common aMCI-related connectivity
changes with small to medium effect sizes and sample size estimates recommending a
minimum of 140 to upwards of 600 total subjects to achieve adequate statistical power
in the context of a multisite study with 5–10 scanning sites and about 10 subjects per
group and per site. If our findings can be replicated and associated with other established
biomarkers of Alzheimer’s disease (e.g., amyloid and tau quantification), then these
functional connections may be promising candidate biomarkers for Alzheimer’s disease.
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INTRODUCTION
Resting-state connectivity in functional magnetic resonance
imaging (fMRI) captures the spatial coherence of spontaneous
fluctuations in blood oxygenation. Resting-state fMRI is a
promising technique that may be useful as an early biomarker
for Alzheimer’s disease (AD), a neurodegenerative process that
develops over decades before patients suffer from dementia.
The possibility that disturbed resting-state connectivity may
be an early marker for AD is supported by studies of
mild cognitive impairment (MCI), a disorder characterized
by objective cognitive deficits without dementia, i.e., without
impairment in activities of daily living, and more specifically by
studies of amnestic MCI (aMCI), the most common subtype of
MCI characterized by memory deficits (Petersen et al., 2001).
These studies showed altered functional connectivity in MCI
compared with cognitively normal elderly (CN; Sorg et al., 2007;
Bai et al., 2009; Liang et al., 2012; Wu et al., 2014), but they
relied on small sample sizes (n = ∼40) and differed in many
aspects of their protocols, e.g., recruitment and image acquisition
procedures. If resting-state fMRI is to serve as a useful biomarker
of AD, or any pathology, for clinical practice or research, we
must determine if changes in functional connectivity differences
between groups of subjects are robust to such variation in study
protocols. Therefore, we sought to identify brain connections
that showed consistent MCI-related changes across multiple
independent studies. If such connections exist, they may be
used as targets to be examined alongside other established AD
biomarkers (e.g., amyloid and tau measures) in order to validate
resting-state fMRI’s potential as a biomarker for AD.
Resting-state connectivity studies have consistently found
decreased connectivity between nodes within the default mode
network (DMN) in patients with AD or MCI compared with CN
(Sorg et al., 2007; Bai et al., 2009; Zhang et al., 2010; Koch et al.,
2012; Liang et al., 2012). Less consistent are reports of alterations
in the executive attentional, frontoparietal, and anterior temporal
networks (Sorg et al., 2007; Zhang et al., 2010; Gour et al., 2011;
Agosta et al., 2012; Liang et al., 2012; Wu et al., 2014) due
to the literature’s bias toward investigating the DMN. Further
inconsistencies can be found in some studies that have reported
increased connectivity between the middle temporal lobe and
other DMN areas in MCI (Qi et al., 2010), while others have
reported decreased connectivity between these same regions (Bai
et al., 2009) and others have reported no significant differences
between MCI and CN (Koch et al., 2012).
One obvious explanation for such inconsistency may be
these studies’ small sample sizes resulting in low statistical
power (Kelly et al., 2012). Beyond this, however, there are
other methodological differences that may compromise the
comparison of results across independent studies. For example,
the criteria for recruiting subjects with MCI, e.g., Petersen (2004)
vs. NIA-AA recommendations (Albert et al., 2011) may differ
among studies. Different study samples may also reflect different
socio-cultural characteristics of recruiting sites, e.g., ethnicity,
language, diet, socioeconomic status. The fMRI measurements
themselves can also be affected by differences in details of the
image acquisition such as scanner make and model (Friedman
et al., 2006), sequence parameters such as repetition time, flip
angle, or acquisition volume (Friedman and Glover, 2006),
experimental design such as eyes-open/eyes-closed (Yan et al.,
2009) or experiment duration (van Dijk et al., 2010), and
scanning environment such as sound attenuation measures
(Elliott et al., 1999), room temperature (Vanhoutte et al., 2006),
or head-motion restraint techniques (Edward et al., 2000).
To identify robust changes in resting-state connectivity
between aMCI and CN, we implemented a meta-analysis of four
independent resting-state fMRI datasets (ADNI2 and three small
single-site studies) using a weighted average implemented by
Willer et al. (2010). Rather than relying on a priori target regions
or connections, we leveraged the large sample size to perform
a systematic search of brain connections affected by aMCI,
an approach termed a “connectome-wide association study”
(Shehzad et al., 2014). In addition, we relied on functionally-
defined brain parcellations using an automated clustering
procedure and we explored the impact of the number of brain
clusters (called resolution) on observed differences (Bellec et al.,
2015).
METHODS
Participants
We combined data from four independent studies: the
Alzheimer’s Disease Neuroimaging Initiative 2 (ADNI2)
sample, two samples from the Centre de recherche de
l’institut universitaire de gériatrie de Montréal (CRIUGMa
and CRIUGMb), and a sample from the Montreal Neurological
Institute (MNI; Wu et al., 2014). All participants gave their
written informed consent to engage in these studies, which
were approved by the research ethics board of the respective
institutions, and included consent for data sharing with
collaborators as well as secondary analysis. Ethical approval was
also obtained at the site of secondary analysis (CRIUGM).
The ADNI2 data used in the preparation of this article were
obtained from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). ADNI was launched in
2003 by the National Institute on Aging, the National Institute
of Biomedical Imaging and Bioengineering, the Food and
Drug Administration, private pharmaceutical companies and
non-profit organizations, as a $60 million, 5-year public-
private partnership representing efforts of co-investigators from
numerous academic institutions and private corporations. ADNI
was followed by ADNI-GO and ADNI-2 that included newer
techniques. Subjects included in this study were recruited by
ADNI-2 from all 13 sites that acquired resting-state fMRI
on Philips scanners across North America. For up-to-date
information, see www.adni-info.org.
The combined sample included 112 CN and 143 aMCI prior
to quality control. After quality control, 99 CN and 129 aMCI
remained. In the CN group, the mean age was 72.0 (s.d. = 7.0)
years, and 37%weremen.Mean age of the aMCI subjects was 72.3
(s.d. = 7.6) years, and 50% were men. An independent samples
t-test did not reveal any significant difference in age between the
groups (t = 0.759, p = 0.448). A chi-squared test revealed a trend
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toward a significant difference in gender distribution between the
groups (χ2 = 3.627, p = 0.057). Note that both age and gender
were entered as confounding variables in the statistical analysis
below. See Table 1 for sample size and demographic information
from the individual studies after passing quality control (for
information about the original cohorts before quality control, see
Supplementary Table 1).
All subjects underwent cognitive testing (e.g., memory,
language, and executive function; see Table 2 for a list of specific
tests used in each study). Exclusion criteria common to all
studies included: Contraindications to MRI, presence or history
of axis I psychiatric disorders (e.g., depression, bipolar disorder,
schizophrenia), presence or history of neurologic disease with
potential impact on cognition (e.g., Parkinson’s disease), and
presence or history of substance abuse. CN subjects could
not meet criteria for MCI or dementia. Those with aMCI
had memory complaints, objective cognitive loss (based on
neuropsychological testing), but had intact functional abilities
and did not meet criteria for dementia. In ADNI2, the diagnosis
of aMCI was made based on an education adjusted abnormal
score on the Logical Memory II subscale (Delayed Paragraph
Recall, Paragraph A only) from the Wechsler Memory Scale and
a Clinical Dementia Rating (CDR) of 0.5. In both CRIUGMa
and CRIUGMb, the diagnosis of aMCI was made based on
scores equal to or >1.5 standard deviations below the mean
adjusted for age and education on memory tests. At the MNI, the
diagnosis of aMCI relied on the Petersen criteria (2004). At both
CRIUGMb and MNI, aMCI diagnoses were made with input
from a neurologist. See the Supplementary Methods (Datasheet
1 in Supplementary Material) for greater details for each study.
Imaging Data Acquisition
All resting-state fMRI and structural scans were acquired on
3T scanners. We performed analyses on the first usable scan
(typically the baseline scan) from ADNI2 and applied clinical
diagnoses from the same study time point as the first usable scan
for each participant in that dataset. See Table 3 for acquisition
parameters for each sample.
Computational Environment
All experiments were performed using the NeuroImaging
Analysis Kit (NIAK1; Bellec et al., 2011) version 0.12.18, under
CentOS version 6.3 with Octave2 version 3.8.1 and the Minc
toolkit3 version 0.3.18. Analyses were executed in parallel on
the “Guillimin” supercomputer4, using the pipeline system for
Octave and Matlab (Bellec et al., 2012), version 1.0.2. The scripts
used for processing can be found on Github5.
Pre-processing
Each fMRI dataset was corrected for slice timing; a rigid-body
motion was then estimated for each time frame, both within and
between runs, as well as between one fMRI run and the T1 scan
for each subject (Collins and Evans, 1997). The T1 scan was itself
non-linearly co-registered to the Montreal Neurological Institute
(MNI) ICBM152 stereotaxic symmetric template (Fonov et al.,
2011), using the CIVET pipeline (Ad-Dab’bagh et al., 2006). The
rigid-body, fMRI-to-T1 and T1-to-stereotaxic transformations
were all combined to resample the fMRI in MNI space at a
3mm isotropic resolution. To minimize artifacts due to excessive
motion, all time frames showing a displacement >0.5mm were
removed (Power et al., 2012). A minimum of 50 unscrubbed
volumes per run was required for further analysis (13 CN and 14
aMCI were rejected from the original cohort of 112 CN and 143
aMCI). Neither the rate of rejection nor the frame displacement
values (before and after scrubbing) varied significantly among the
1http://simexp.github.io/niak/.
2https://www.gnu.org/software/octave/.
3http://www.bic.mni.mcgill.ca/ServicesSoftware/ServicesSoftwareMincToolKit.
4http://www.calculquebec.ca/en/resources/compute-servers/guillimin.
5https://github.com/SIMEXP/mcinet.
TABLE 1 | Demographic information in all studies after quality control.
ADNI2 CRIUGMa CRIUGMb MNI Combined sample
CN N 49 18 17 15 99
Mean age (s.d.) 74.4 (6.8) 71.2 (8.0) 70.4 (4.6) 67.0 (5.7) 72.0 (7.0)
Number male (%) 21 (43%) 7 (39%) 2 (12%) 7 (47%) 37 (37%)
Mean years of education (s.d.)a 16.9 (2.2) 14.9 (2.3) 15.1 (2.8) 15.0 (3.1) 16.0 (2.6)
MMSE mean (range) 28.7 (25–30) 28.8 (27–30) n/a 29.0 (27–30) n/a
MoCA mean (range) n/a 27.8 (22–30) 28.4 (26–30) n/a n/a
aMCI N 82 8 21 18 129
Mean age (s.d.) 71.2 (7.3) 79.9 (6.1) 74.8 (7.0) 71.2 (8.1) 72.3 (7.6)
Number male (%) 43 (52%) 3 (38%) 12 (57%) 7 (39%) 65 (50%)
Mean years of education (s.d.)a 16.2 (2.6) 13.7 (3.8) 14.8 (4.2) 13.1 (3.1) 15.5 (3.2)
MMSE mean (range) 28.1 (24–30)* 26.1 (22–29)* n/a 26.1 (22–30)* n/a
MoCA mean (range) n/a 23.3 (20–29)* 24.6 (16–29)* n/a n/a
MMSE, Mini-mental state examination; MoCA, Montreal Cognitive Assessment.
*Significant difference between aMCI and CN (within study) for independent samples t-test at p ≤ 0.05.
aMissing values for education for subjects in ADNI2 (1 CN, 1 aMCI), CRIUGMb (2 aMCI), and MNI (3 CN, 6 aMCI).
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TABLE 2 | Neuropsychological tests that were used in each study.
Test ADNI2 CRIUGMa CRIUGMb MNI
Mini-mental state examination (MMSE) x x x
Montreal Cognitive Assessment (MoCA) x x x
Clinical Dementia Rating (CDR) x x
ADAS-Cog x
Everyday Cognition (ECog) x
Trail making x x x x
(Trails A and B) (Trails A and B) (Trails A and B) (DKEFS)
Boston naming test x x x x
Digit span x x x
Color-word interference (DKEFS) x x x
Rey auditory verbal learning test x x x
Verbal fluency x x x (MEC) x (DKEFS)
Clock drawing x x
Visual object and space perception battery x
Brixton spatial anticipation test x
Hooper visual organization test x
Rey complex figure x x x
Aggie figures learning test x
16-Item free and cued recall (RL/RI-16) x
Pyramid and palm trees test x
Weschler memory scale—logical memory subtest x x x
MEC, Montréal évaluation de la communication; DKEFS, Delis–Kaplan Executive Function System.
four samples or between CN and aMCI. The following nuisance
covariates were regressed out from fMRI time series: slow time
drifts (basis of discrete cosines with a 0.01Hz high-pass cut-off),
average signals in conservative masks of the white matter and the
lateral ventricles as well as the first 3–10 principal components
(median numbers for ADNI2, CRIUGMa, CRIUGMb, and MNI
were 9, 6, 7, and 7, respectively, and accounting for 95% variance)
of the six rigid-body motion parameters and their squares (Lund
et al., 2006; Giove et al., 2009). The fMRI volumes were finally
spatially smoothed with a 6mm isotropic Gaussian blurring
kernel. A more detailed description of the pipeline can be found
on the NIAK website6 and Github7.
Bootstrap Analysis of Stable Clusters
(BASC)
We applied a BASC to identify clusters that consistently exhibited
similar spontaneous BOLD fluctuations in individual subjects,
and were spatially stable across subjects. We first applied a
region-growing algorithm to reduce each fMRI dataset into
a time × space array, with 957 regions (Bellec et al., 2006).
BASC replicates a hierarchical Ward clustering 1000 times and
computes the probability that a pair of regions fall in the same
cluster, a measure called stability. The region × region stability
matrix is fed into a clustering procedure to derive consensus
clusters, which are composed of regions with a high average
probability of being assigned to the same cluster across all
6http://niak.simexp-lab.org/pipe_preprocessing.html.
7https://github.com/SIMEXP/mcinet/tree/master/preprocess.
replications. At the individual level, the clustering was applied to
the similarity of regional time series, which was replicated using
a circular block bootstrap. Consensus clustering was applied to
the average individual stability matrix to identify group clusters.
The group clustering was replicated via bootstrapping of subjects
in the group. A consensus clustering was finally applied on the
group stability matrix to generate group consensus clusters.
The cluster procedure was carried out at a specific number
of clusters (called resolution). Using a “multiscale stepwise
selection” (MSTEPS) method (Bellec, 2013), we determined a
subset of resolutions that provided an accurate summary of the
group stability matrices generated over a fine grid of resolutions:
4, 6, 12, 22, 33, 65, 111, and 208.
Derivation of Functional Connectomes
For each resolution K, and each pair of distinct clusters,
the between-clusters connectivity was measured by the Fisher
transform of the Pearson’s correlation between the average time
series of the clusters. The within-cluster connectivity was the
Fisher transform of the average correlation between time series
inside the cluster. An individual connectome was thus a K × K
matrix. See Figures 1A,B for an illustration of a parcellation and
associated connectome.
Statistical Testing
To test for differences between aMCI and CN at a given
resolution, we used a general linear model (GLM) for each
connection between two clusters. The GLM included an
intercept, the age and sex of participants, and the average frame
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TABLE 3 | Structural and functional scan acquisition parameters.
ADNI2a CRIUGMa CRIUGMb MNI
Scanner manufacturer Philips Siemens Siemens Siemens
STRUCTURAL
No. channels 8 32 32 32
No. slices 170 176 176 176
Slice thickness (mm) 1.2 1 1 1
In-plane resolution (mm × mm) 1× 1 1× 1 1 ×1 1× 1
Matrix size 256× 256 240× 256 256× 256 256× 256
FOV (mm2) 256 240/256 256 256
TR (s) 6.8 2.3 2.53 2.3
TE (ms) 3.09 2.91 1.64 2.98
TI (s) n/a 0.9 1.2 0.9
FA (◦) 9 9 7 9
Slice gap 0 0 0 0
Imaging plane Sagittal Sagittal Sagittal Sagittal
NEX 1 1 1 1
FUNCTIONAL
No. runs 1 1 3 3
No. channels 8 32 32 32
No. volumes 140 240 150 160
No. slices 48 33 42 38
Slice thickness (mm) 3.3 4 3.4 3.6
In-plane resolution (mm × mm) 3.3× 3.3 3× 3 3.4× 3.4 3.6× 3.6
Matrix size 64× 64 64× 64 64× 64 64× 64
FOV (mm2) 212 192 218 230
TR (s) 3 2 2.6 2
TE (ms) 30 30 30 30
FA (◦) 80 90 90 90
Slice gap 0 0 0 0
Imaging plane Axial Axial Axial Axial
NEX 1 1 1 1
Total scan time (min:s) 7:00 8:00 19:30 16:00
ahttp://adni.loni.usc.edu/wp-content/uploads/2011/04/ADNI_3T_Philips_2.6.pdf.
displacement of the runs involved in the analysis. The contrast
of interest (aMCI–CN) was represented by a dummy covariate
coding the difference in average connectivity between the two
groups. All covariates except the intercept were corrected to a
zero mean (Figure 1C). The GLM was estimated independently
for each scanning protocol. In addition to distinguishing
between CRIUGMa, CRIUGMb, MNI, and ADNI2, ADNI2 was
subdivided into five sub-studies based on the use of different
Philips scanner models (i.e., Achieva, Gemini, Ingenia, Ingenuity,
and Intera). We dropped all subjects scanned with Ingenuity
(2 CN, 1 aMCI) due to the elimination of all aMCI subjects
within that site by the scrubbing procedure and its small
sample size. We therefore estimated seven independent GLMs
for each protocol (ADNI2-Achieva, ADNI2-Gemini, ADNI2-
Ingenia, ADNI2-Intera, CRIUGMa, CRIUGMb, MNI). The
estimated effects were combined across all protocols through
inverse variance based weighted averaging (Willer et al., 2010;
Figure 1D).
Resolutions containing fewer than 50 clusters have been
suggested to have higher sensitivity based on prior independent
work (Bellec et al., 2015). The GLM was first applied at an a
priori resolution of K = 33, which was the lowest number
of clusters for which the DMN could be clearly decomposed
into subnetworks (Supplementary Figure 1, visit Figshare for 3D
volumes of brain parcellations8 and see Supplementary Table 2
for a list of the 33 clusters and their numerical IDs). The false-
discovery rate (FDR) across connections was controlled at qFDR
≤ 0.1 (Benjamini andHochberg, 1995). In addition to the analysis
at resolution 33, we assessed the impact of that parameter by
replicating the GLM analysis at the seven resolutions selected
by MSTEPS (Supplementary Figure 2). We implemented an
omnibus test (family-wise error rate α≤ 0.05) to assess the overall
presence of significant differences between groups, pooling FDR
results across all resolutions (Bellec et al., 2015). If the omnibus
test across resolutions was not significant, then no test would
be deemed significant. Since this omnibus test was significant,
we used the FDR threshold of q ≤ 0.1 to explore single
resolutions.
RESULTS
Functional Connectivity Differences
Between aMCI and CN
The omnibus test pooling significant differences in connectivity
between aMCI and CN across all resolutions was significant at
α ≤ 0.05 (p ≤ 0.0056). In line with prior observations on
independent datasets (Bellec et al., 2015), resolutions containing
fewer than 50 clusters were associated with a higher rate
of discovery (Figure 2). At resolution 33, significant group
differences between aMCI and CN were seen across the whole
brain (Figure 3A). Four brain clusters were associated with 47%
of all significant changes found across the connectome: the
superior medial frontal cortex (including anterior cingulate),
dorsomedial prefrontal cortex, striatum, and middle temporal
lobe (Figures 3B,C, Supplementary Table 3). Supplementary
Table 3 contains a list of parcels that account for all non-
redundant significant connectivity differences between aMCI
and CN. For example, the first-ranked seed (superior medial
frontal cortex) was associated with 13.4% of connections that
differ between the groups. The second-ranked seed (dorsomedial
prefrontal cortex) was associated with an additional 12.7% of
connectivity differences that did not overlap with or were not
previously accounted for by the first seed. Note that if a given
parcel was associated with a significant effect with another region
that ranked in the table, then that parcel may not be listed in
the table (i.e., this table is not a comprehensive list of parcels
that show significant effects, as a given parcel may involve a
region in the table at a higher rank which already accounted
for its effects). Given that the top four clusters explained nearly
half of the findings, they were further characterized in seed-
based connectivity analyses, which revealed that aMCI showed
decreased connectivity between DMN nodes and between
areas of the cortico-striatal-thalamic loop (Figure 4). More
specifically, in aMCI compared to CN, the superior medial
frontal cortex displayed significantly reduced connectivity with
8http://dx.doi.org/10.6084/m9.figshare.1480461.
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FIGURE 1 | Application of general linear models to connectomes. (A) The brain is functionally parcellated into K (e.g., 50) clusters generated through a
clustering algorithm. (B) The connectome is a K × K matrix measuring functional connectivity between and within clusters. (C) A general linear model is used to test
the association between phenotypes and connectomes, independently at each connection, at the group level. (D) In a multisite situation, independent site-specific
effects are estimated and then pooled through weighted averaging (Willer et al., 2010).
the ventromedial prefrontal cortex, striatum, thalamus, temporal
lobes, hippocampus, inferior parietal lobes, and precuneus
(Figure 4A). aMCI showed reduced connectivity between the
dorsomedial prefrontal cortex with temporal lobe regions, ventral
frontal areas, thalamus, striatum, and the cuneus (Figure 4B).
The striatum in aMCI also exhibited decreased connectivity
with the sensorimotor cortex, thalamus, and frontal and parietal
regions (Figure 4C). Lastly, in aMCI, the middle temporal lobe
displayed significantly decreased connectivity with the posterior
cingulate, precuneus, inferior parietal lobes, hippocampus, and
frontal areas (Figure 4D).
Sample-Specific Effects
The statistical model we used to combine GLM analyses across
sites was based on a weighted average. The possibility thus
existed that an effect would be significant in the pooled analysis
because it was driven by a very strong effect in a single sample,
instead of being consistent across all samples.Whenwe examined
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FIGURE 2 | Plot of the percentage of connections identified as
significant by the statistical comparison between aMCI and CN across
the connectome (qFDR ≤ 0.1), as a function of the resolutions selected
by MSTEPS.
FIGURE 3 | (A) Map of the percentage of connections associated with a given
cluster and identified as significant by the statistical comparison between aMCI
and CN, at a resolution of 33 clusters (qFDR ≤ 0.1). (B) Maximum absolute
difference in average connectivity between aMCI and CN, across all
connections associated with a cluster, at resolution 33. 1F(r) signifies the
difference in Fisher-transformed correlation values between the groups. (C)
Four clusters of interest (superior medial frontal cortex, dorsomedial prefrontal
cortex, striatum, middle temporal lobe) were selected out of 33 for further
characterization.
effects in each sample independently, we detected no findings or
very few significant findings. We then explored the whole brain
connectivity of the top four seed regions (superior medial frontal
cortex, dorsomedial prefrontal cortex, striatum, and middle
temporal lobe) within each sample. The majority of effects found
at each sample did not appear to be consistent or reproducible
across studies as the comparison between aMCI and CN varied
substantially among the seven samples (Figure 5, Supplementary
Figures 3–5). We assessed the extent at which findings among the
seven samples were similar by calculating correlation coefficients
across the spatial maps for the average connectivity values in
CN, the average connectivity values in aMCI, and differences in
connectivity values between aMCI and CN among the samples.
We found that the difference maps, contrasting aMCI and CN,
were weakly correlated on average across studies and protocols
(mean r = 0.06, min r = −0.64, max r = 0.69). The average
connectivity maps among studies in both CN and aMCI were
generally highly correlated with each other (for CN, mean r =
0.68, min r = −0.16, max r = 0.95; for aMCI, mean r = 0.67,
min r =−0.10, max r = 0.97). These results were expected given
the small sample sizes of most independent samples (Kelly et al.,
2012), but still sobering as the majority of the literature on aMCI
and fMRI has used small sample sizes.
However, despite the large observed variations in the spatial
distribution of aMCI vs. CN contrasts, there were still clear
consistent trends across studies and protocols. We indeed
found that aMCI-related connectivity changes that surpassed
the FDR threshold in the pooled analysis showed similar
trends in the vast majority of samples across seeds and
connections, where the independent aMCI samples consistently
exhibited decreased connectivity compared to the CN samples
(Figures 5, 6, Supplementary Figures 3–5). For example, the
pooled analysis revealed that, compared to CN, aMCI exhibited
significantly reduced connectivity between the superior medial
frontal cortex cortex (the region in which connectivity was most
affected by aMCI) and the middle temporal lobes. This change
appeared to be common to the majority of the independent
samples (Figures 5, 6A). For this particular seed, the change in
connectivity was mainly due to regions with positive correlations
in CN having smaller correlation values closer to zero in aMCI
in the individual samples (Figures 5, 6A). For sample-specific
effects in other seeds and connections, please see Supplementary
Figures 3–9.
Effect Sizes and Sample Size Estimates
We measured the effect sizes of the difference between groups
at each significant connection by calculating Cohen’s d, via a
weighted average of the effect sizes per individual sample. We
found small to medium effect sizes, ranging from d = 0.10–0.48,
with an average effect size of d = 0.32. Note that these effect
sizes are potentially inflated since we have focussed on significant
results only. We also calculated the sample sizes required to
achieve 80% power, based on the effect sizes estimated by Cohen’s
d, the assumption of balanced groups, Gaussian distributions,
bilateral tests, and α = 0.05, for each connection. We found that
the estimated sample sizes ranged from 140 to upwards of 600
total subjects, which further suggests that findings from small
samples, similar to the seven samples we included when assessed
independently, are not expected to be reliable. As noted above, as
we used the same sample to estimate the location of effects and
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FIGURE 4 | Effect maps for a selection of four seeds that show effects related to aMCI at resolution 33. Effect maps reveal the spatial distribution of the
changes in functional connectivity for (A) the superior medial frontal cortex, (B) the dorsomedial prefrontal cortex, (C) striatum, and (D) the middle temporal lobe. All
connections shown in the maps of difference in average connectivity between aMCI and CN are significant at qFDR ≤ 0.1. For each panel, the top line maps the
spatial location of the seed region in magenta, the second and third lines show the connectivity (Fisher-transformed correlation values, F(r)) between the designated
seed region and the rest of the brain in CN and aMCI, respectively, and the fourth line shows a difference map between aMCI and CN [difference in Fisher-transformed
correlation values, 1F(r)]. The numbers in parentheses refer to the numerical IDs of the clusters in the 3D parcellation volume, as listed in Supplementary Table 2.
their size, these sample size estimates are possibly optimistic, i.e.,
deflated compared to a replication on an independent sample.
See Figure 6 and Supplementary Figures 6–9 for Cohen’s d and
sample size estimates for each significant connection that was
reported in Figure 4.
Effect of Resolution on the GLM
The percentage of discoveries in significant differences between
aMCI and CN across the connectomes varied markedly as a
function of resolution, as selected by the MSTEPS procedure.
Higher resolutions were associated with fewer discoveries,
especially beyond resolution 65 (Supplementary Figure 10A).
By contrast, the maximal amplitude of differences in average
connectivity associated with a particular cluster did not
decrease substantially, and sometimes increased, when the
resolution increased (Supplementary Figure 10B). The decrease
in percentage of discovery thus likely reflected a cost associated
with an increased number of multiple comparisons in the FDR
procedure, rather than a loss in signal quality. Regarding the
clusters that were selected for our seed-based analyses (the
superior medial frontal cortex, dorsomedial prefrontal cortex,
striatum, and middle temporal lobe), the associated effect maps
(without statistical threshold) were highly consistent across
different resolutions (Supplementary Figures 11, 12), with the
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FIGURE 5 | Comparisons of effects in the superior medial frontal cortex across samples. This figure illustrates functional connectivity changes between aMCI
and CN, average connectivity in CN, and average connectivity in aMCI in each site (ADNI2-Achieva, ADNI2-Gemini, ADNI2-Ingenia, ADNI2-Intera, CRIUGMa,
CRIUGMb, MNI) independently of other sites and when samples are pooled together (all samples). The number in parentheses refers to the numerical ID of the seed in
the 3D parcellation volume, as listed in Supplementary Table 2.
potential exception of very low resolutions where, for example,
a relatively small cluster like the anterior cingulate got merged
with a large distributed cortical network. This also replicated
a prior study on the effect of multiresolution parcellations on
GLM analysis (Bellec et al., 2015). Lastly, signal-to-noise ratio
did not have a significant impact on the results (Supplementary
Figure 13).
DISCUSSION
We report resting-state functional connectivity differences in the
superior medial frontal cortex, dorsomedial prefrontal cortex,
striatum, and middle temporal lobe between aMCI and CN
subjects when multiple studies were combined together. Despite
protocol differences, we found that aMCI exhibited reduced
connectivity within areas of the DMN and cortico-striatal-
thalamic loop compared to CN. Previous studies suggested
these altered patterns of functional connectivity in MCI may
result from the coevolution of multiple AD-associated biological
processes, namely structural degeneration (Pievani et al., 2010;
Coupé et al., 2012), neurofibrillary and amyloid pathologies
(Small et al., 2006), and cerebrovascular dysfunction (Villeneuve
and Jagust, 2015).
The superior medial frontal cortex andmiddle temporal lobes,
both of which are DMN nodes, were among the seed regions
with the greatest amount of aMCI-related connectivity changes
with other brain areas. Decreased connectivity in aMCI patients
was found between these two nodes and other DMN regions,
including the posterior cingulate, precuneus, inferior parietal
lobes, ventromedial prefrontal cortex, and hippocampus. Our
findings support previous studies that used small single-site
samples and reported reduced DMN connectivity in MCI and
AD patients (Sorg et al., 2007; Bai et al., 2009; Agosta et al.,
2012; Koch et al., 2012). Alterations in the DMN may reflect
increased amyloid burden in aMCI patients as it has been shown
that amyloid plaques impair default mode connectivity (Hedden
et al., 2009; Sheline et al., 2010b; Mormino et al., 2011).
We found reduced connectivity within the frontal lobes,
notably between ventral and dorsal areas. Decreased functional
connectivity between the ventral and dorsal frontal regions
could reflect degeneration in gray matter and in white matter
tracts connecting these areas. Longitudinal studies have shown
greater prefrontal cortex atrophy in MCI over time, as well
as in those transitioning to AD, compared to CN (McDonald
et al., 2009; Carmichael et al., 2013). Cortico-cortical white
matter bundles, e.g., superior longitudinal fasciculus, have also
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FIGURE 6 | Mean connectivity between (A) the superior medial frontal cortex and middle temporal lobe, (B) the dorsomedial prefrontal cortex and
middle frontal gyrus, (C) the striatum and pre/postcentral gyrus, and (D) middle temporal lobe and posterior cingulate in CN and aMCI in the
independent samples. Each map displays the seed (pink) and a selected cluster (blue) whose connectivity with the seed significantly differed between CN and aMCI
in the pooled analysis. The box-whisker plots display the mean connectivity (Fisher-transformed correlation values) between the seed and the selected parcel, overlaid
(Continued)
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FIGURE 6 | Continued
over individual data points, in the CN and MCI groups in the ADNI2-Achieva, ADNI2-Gemini, ADNI2-Ingenia, ADNI2-Intera, CRIUGMa, CRIUGMb, and MNI samples.
We also report the Cohen’s d (a weighted average of the effect sizes per sample) followed by a sample size estimate (for 80% power, balanced groups, bilateral tests,
Gaussian distributions, and α = 0.05) in square brackets in the top-right corner of each plot. The numbers in parentheses in the titles refer to the numerical IDs of the
seeds in the 3D parcellation volume, as listed in Supplementary Table 2. For box-whisker plots for all significant clusters with each of these seeds, see Supplementary
Figures 6–9.
been demonstrated to degenerate in patients with MCI and
AD (Pievani et al., 2010). Additionally, functional connectivity
changes may reflect the regional effect of increased amyloid
burden (Sheline et al., 2010b), and PIB-PET work has shown
the frontal lobe to be one of the first regions in which
amyloid accumulates in autosomal dominant AD mutation
carriers (Bateman et al., 2012). Our results may also be due to
neurofibrillary pathology as it typically appears in the prefrontal
cortex during MCI (Bossers et al., 2010). Lastly, cerebral
hypoperfusion in the frontal lobe of MCI (Chao et al., 2009) may
have contributed to our results.
We also observed functional disconnection between the
temporal and frontal lobes in aMCI. Effects in the temporal
lobes were expected given that the temporal lobe is a region
known to suffer from significant AD pathology in preclinical
phases (Guillozet et al., 2003). Structural connectivity may also
explain the functional connectivity changes between the frontal
and temporal regions, since degeneration of white matter tracts
between these areas, e.g., the uncinate fasciculus, occurs with
the progression from MCI to AD and correlates with episodic
memory impairment in MCI (Pievani et al., 2010; Rémy et al.,
2015). Furthermore, examining the integrity of the arcuate
fasciculus, a major language tract that connects the frontal
and temporal lobes (Dick and Tremblay, 2012), might reveal a
biological basis for language impairments such as word-finding
difficulties in MCI and AD, (Nutter-Upham et al., 2008). Brain
areas that subserve language function could be important targets
to investigate given recent evidence that multilingualism, like
other forms of cognitive reserve, may help delay the onset of AD
(Chertkow et al., 2010).
Unexpectedly, we also found significant effects in the
striatum, which showed reduced connectivity in aMCI with the
sensorimotor cortex, frontal and parietal regions, and thalamus.
While not initially expected, these findings may reflect earlier
observations that regions within the cortico-striatal-thalamic
loops are vulnerable to AD pathology. For example, previous
work demonstrated the presence of substantial amyloid burden
in the striatum in both autosomal dominant and sporadic forms
of AD (Braak and Braak, 1990; Villemagne et al., 2009), and the
striatum may be the first region in which amyloid deposition
occurs in autosomal dominant AD (Klunk et al., 2007; Bateman
et al., 2012). Furthermore, significant neurodegeneration is
known to occur with AD in the striatum and thalamus (de
Jong et al., 2008; Madsen et al., 2010), so our results might
reflect the brain’s capacity for functional plasticity in response
to amyloid or neurodegeneration in these regions. Motor cortex
hyperexcitability has also been shown in AD, and this suggests
that inhibitory circuits leading to the motor cortex may be
affected in the disease (Ferreri et al., 2011). Patients with
AD also demonstrate changes in swallowing which have been
associated with altered cortical activity (Humbert et al., 2010).
Our results may support these observations. Additionally, our
findings may represent a biological basis for the cognitive and
motor symptoms of MCI (Aggarwal et al., 2006) since the
striatum and the rest of the basal ganglia have been implicated in
stimulus-response associative learning and memory and motor
skill acquisition and execution (Packard and Knowlton, 2002;
Doyon et al., 2009). Future research should examine the potential
relationship between connectivity in the cortico-striatal-thalamic
loops and motor function in aMCI and AD.
Our findings contrasted with previous, smaller single-site
studies that have variously reported decreased and increased
connectivity. The reports of increased connectivity (Bai et al.,
2009; Qi et al., 2010; Gour et al., 2011) may have reflected
unique attributes of particular protocols or the choices made with
respect to pre-processing steps, for example using global signal
regression (Saad et al., 2012). Given that our sample size estimates
suggest the use of hundreds of subjects to obtain adequate
statistical power, it is not surprising that discrepancies between
our results and previous findings generated from smaller,
likely underpowered, studies exist. Even when we examined
the samples in our study (ADNI2-Achieva, ADNI2-Gemini,
ADNI2-Ingenia, ADNI2-Intera, CRIUGMa, CRIUGMb, MNI)
independently of each other, we found inconsistent effects among
the samples. It is only by combining the studies together in a
meta-analysis that we were able to find some common differences
in functional connectomes between patients with aMCI and CN.
This finding underscores the need for multisite studies with
large sample sizes in order to generate reproducible results, as
previously suggested in the field of autism research (Haar et al.,
2014).
Among our study’s limitations is that it was not possible to
model each of the 13 ADNI2 sites independently because the
sites tended to be small and unbalanced in the numbers of
patients and controls. We therefore chose to model each scanner
model within ADNI2 separately based on the recommendation
of a reviewer. A previous version of the analysis (published as
a preprint9) had not modeled the different scanner models in
ADNI2 and instead treated ADNI2 as a single site. This previous
analysis yielded fewer significant findings, but the results were
still mostly consistent with what is reported here. Our results
suggest that modeling scannermodels may have a positive impact
on fMRI association studies, but further experiments would be
required to confirm that this trend is reproducible. We must
also note that the METAL averaging is only representative of
the specific samples that were averaged, especially using only
9http://dx.doi.org/10.1101/019646.
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Philips and Siemens scanners, and it is unclear how our findings
may replicate in other studies that would employ a different
combination of protocols, say using GE scanners. In particular,
our sample size estimates have to be interpreted with caution.
They may first be under-estimated, because they were not
derived from pre-specified locations, but rather associated with
the connections showing the largest effects in our particular
sample. These sample sizes were also derived from a meta-
analysis combining particular types of studies. We only had 3T
scanners from two manufacturers, Siemens and Philips. For the
Siemens studies, all were from the same model. For the Philips
studies, the scanning protocol was identical at every site, and
only the scanner model varied across scanners. Finally, a fairly
large number of patients and controls (generally more than 10
subjects per group) was scanned for each variant of the scanning
protocol. The sample size estimate may turn out quite differently
for a single site study or on the contrary for a study with a
very large number of sites and with only a few subjects per
site.
Our study is also limited by its cross-sectional nature, which
precludes inference that the functional changes we found would
necessarily predict progression toward Alzheimer’s dementia.
Furthermore, aMCI has many underlying causes aside from AD.
It is possible that some subjects in our cohort had cognitive
impairments due to Lewy Body dementia, for example. However,
all samples in the current study had inclusion criteria that
enriched for subjects that had aMCI likely due to AD and
excluded aMCI subjects with other co-morbidities, such as
depression or Parkinson’s disease. Also, we did not account
for structural atrophy, despite a bias for increased detection in
functional differences due to differences in underlying structure
(Dukart and Bertolino, 2014). However, aMCI-related gray
matter changes likely co-localize to some extent with functional
changes, and the aim of our work was to map out functional
changes rather than study their interaction with atrophy. We
did not account for other variables, such as APOE genotype
(Sheline et al., 2010a), amyloid deposition (Sheline et al., 2010b),
presence of neurofibrillary tangles (Maruyama et al., 2013),
and cerebrovascular mechanisms (Villeneuve and Jagust, 2015).
At least some of these could potentially have explained the
observed aMCI-related functional connectivity changes as part
of an underlying disease mechanism. Large-scale multimodal
studies, incorporating genomics, proteomics, and multimodal
imaging will be needed to identify the interactions between
these and other physiological facets of the pathology. Despite
combining several samples together, we still only achieved
relatively limited power, given that sample size estimates required
at least 140 to over 600 total subjects to consistently identify
effects between groups. Lastly, because of the explorative
approach used in our study, the resulting estimates of effect sizes
may have been inflated and discussion of possible pathological
mechanisms for our findings was speculative. However, our
discoveries may be used as follow-up targets in future work.
Upcoming research should not only attempt to verify our
findings by using these regions and their associated connections
with hypothesis-driven approaches (e.g., seed-based correlation
analyses), but also to extend them to cohorts that include
Alzheimer’s dementia and other clinical populations (e.g., CN
with significant amyloid deposition) and to longitudinal studies
that characterize individuals’ progression to dementia. Finally,
future studies should aim to determine whether our findings
are associated with established biomarkers of AD (e.g., amyloid
and tau quantification) in order to probe the potential of these
functional connections as biomarkers.
Overall, our results supported previous findings of DMN
connectivity changes in AD and MCI (Greicius et al., 2004; Sorg
et al., 2007), given that three of the identified seeds (superior
medial frontal cortex, dorsomedial prefrontal cortex, middle
temporal lobe) are part of this network. It is noteworthy, however,
that our strongest observed effects reported here were not in
the same DMN regions typically described in earlier resting-
state studies of MCI and AD, viz, posterior cingulate/precuneus
(Sheline et al., 2010b; Zhang et al., 2010). Unexpected changes
were also found in the striatum, and this may reflect the
advantages of “mining” the whole-brain connectome to search
for new biomarkers of mild cognitive impairment and possibly
the early progression of the pathophysiologic substrate of
Alzheimer’s disease. If confirmed, our results could suggest the
utility of these regions in resting-state fMRI as a biomarker
endpoint in clinical trials.
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